SMAD7 and atherosclerosis: And increased DNA methylation levels of the SMAD7 promoter at CpG unit 5.8.15.16 were found in the peripheral blood of patients with atherosclerosis compared with normal controls, suggesting that methylated SMAD7 may be a novel predictive marker for atherosclerosis (Wei, et al., 2018).